CMS Proposes to Spin-off and Separately List the Shares of Dermavon on the Main Board of HKEX
2025-04-22

CMS Proposes to Spin-off and Separately List the Shares of Dermavon on the Main Board of HKEX

Self-developed Innovative Drug Cardiac Myosin Inhibitor CMS-D003 is Approved for Drug Clinical Trials
2025-03-12

Self-developed Innovative Drug Cardiac Myosin Inhibitor CMS-D003 is Approved for Drug Clinical Trials

Included in the S&P Global Sustainability Yearbook 2025
2025-02-13

Included in the S&P Global Sustainability Yearbook 2025

Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10
2025-01-24

Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Rα Monoclonal Antibody MG-K10

Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
2025-01-08

Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type